Sanctuary Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$49.2K Hold
277
0.03% 90
2024
Q3
$54.7K Sell
277
-10
-3% -$1.87K 0.04% 94
2024
Q2
$49.2K Hold
287
0.04% 88
2024
Q1
$52.3K Hold
287
0.04% 88
2023
Q4
$44.5K Hold
287
0.04% 91
2023
Q3
$42.8K Hold
287
0.05% 80
2023
Q2
$38.7K Buy
+287
New +$42.1K 0.04% 86
2022
Q4
$46.4K Buy
+287
New +$44K 0.05% 72

Other funds holding ABBV

Sanctuary Wealth Management's ABBV Position: Q4 2024 in Review

Sanctuary Wealth Management held its AbbVie (ABBV) position steady in Q4 2024 at 277 shares worth $49.2K. The position accounts for 0.03% of the portfolio, ranked #90.

Sanctuary Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. The position peaked at $54.7K in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Sanctuary Wealth Management held 277 shares of AbbVie worth $49.2K as of Q4 2024.
  • Sanctuary Wealth Management left its AbbVie share count unchanged in Q4 2024.
  • AbbVie made up 0.03% of Sanctuary Wealth Management's portfolio in Q4 2024, its #90 holding.
  • Sanctuary Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
  • Sanctuary Wealth Management's AbbVie position peaked at $54.7K in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.